CPIX
Cumberland Pharmaceuticals Inc.
Halal Rating :
Last Price
$2.57
Last updated:
Market Cap
-
7D Change
10.3%
1 Year Change
32.47%
Company Overview
Industries
Exchange
Next Earnings Date
Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company that focuses on acquiring, developing, and commercializing branded prescription products. The company's product portfolio includes treatments for hospital acute care, gastroenterology, and rheumatology. Their key products include Acetadote® (acetylcysteine) for acetaminophen poisoning, Caldolor® (ibuprofen) for pain and fever, Kristalose® (lactulose) for constipation, and Vaprisol® (conivaptan) for hyponatremia.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $9.09m | $10.92m | - | $137374.0 | 0.00% | 1.26% |
| June 30, 2024 | $9.85m | $11.0m | - | $126347.0 | 0.00% | 1.15% |
| March 31, 2024 | $8.5m | $10.49m | - | $118526.0 | 0.00% | 1.13% |
Company Impact
Help us evaluate Cumberland Pharmaceuticals Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.